TrialJournal of patient-reported outcomes2024

Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.

Lene Kongsgaard Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.